SCM
PBYI icon

Sio Capital Management’s Puma Biotechnology PBYI Stock Holding History

Sio Capital Management’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-32,832
Closed -$1.5M – 82
2018
Q3 		$1.5M Buy
+32,832
New +$1.58M 0.52% 50
2018
Q1 		– Sell
-12,209
Closed -$1.21M – 41
2017
Q4 		$1.21M Sell
12,209
-15,012
-55% -$1.68M 0.68% 35
2017
Q3 		$3.26M Sell
27,221
-52,800
-66% -$4.91M 1.69% 22
2017
Q2 		$6.99M Sell
80,021
-80,043
-50% -$4.48M 3.32% 9
2017
Q1 		$5.95M Buy
+160,064
New +$5.84M 3.33% 9

Other funds holding PBYI

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Sio Capital Management's PBYI Position: Q4 2018 in Review

Sio Capital Management sold out of Puma Biotechnology (PBYI) in Q4 2018, closing a stake of 32,832 shares — an estimated $1.5M sold.

Sio Capital Management first reported a position in PBYI in Q1 2017 and held it in 5 quarters. The position peaked at $6.99M in Q2 2017. 141 funds tracked by Wall St. Rank hold PBYI as of Q4 2018.

  • Sio Capital Management reported no remaining Puma Biotechnology position as of Q4 2018 after selling out during the quarter.
  • Sio Capital Management sold 32,832 Puma Biotechnology shares in Q4 2018, an estimated $1.5M.
  • Sio Capital Management first reported a position in Puma Biotechnology in Q1 2017 and held it in 5 quarters.
  • Sio Capital Management's Puma Biotechnology position peaked at $6.99M in Q2 2017.
  • 141 funds tracked by Wall St. Rank held Puma Biotechnology as of Q4 2018.

Based on Sio Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.